Status: Not yet recruiting
Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer
The objective of this study is to assess two novel positron emission tomography (PET) radiotracers, \[64Cu\]CM500 and \[68Ga\]CM500, for Positron Emission Tomography-Magnetic Resonance Imaging (PET-MR) and Positron Emission Tomography / Computed Tomography (PET-CT) imaging of solid tumors. These tracers have the potential to detect solid tumors throughout the body and may enable doctors to identify smaller tumors than conventional imaging techniques.
Participants needed: 40
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Lumina Pharmaceuticals IncUpdated: Aug 28, 2026Locations: 3
Eligibility criteria
18 years of age or older; [+7]
Less than 18 years of age; [+15]